
Drug repurposing is a valuable strategy for rapidly developing drugs for treating COVID-19. This study aimed to evaluate the antiviral effect of six antiretrovirals against SARS-CoV-2 in vitro and in silico.
The cytotoxicity of lamivudine, emtricitabine, tenofovir, abacavir, efavirenz and raltegravir on Vero E6 was evaluated by MTT assay. The antiviral activity of each of these compounds was evaluated via a pre-post treatment strategy. The reduction in the viral titer was assessed by plaque assay. In addition, the affinities of the antiretroviral interaction with viral targets RdRp (RNA-dependent RNA polymerase), ExoN-NSP10 (exoribonuclease and its cofactor, the non-structural protein 10) complex and 3CLpro (3-chymotrypsin-like cysteine protease) were evaluated by molecular docking.
Lamivudine exhibited antiviral activity against SARS-CoV-2 at 200 µM (58.3%) and 100 µM (66.7%), while emtricitabine showed anti-SARS-CoV-2 activity at 100 µM (59.6%), 50 µM (43.4%) and 25 µM (33.3%). Raltegravir inhibited SARS-CoV-2 at 25, 12.5 and 6.3 µM (43.3%, 39.9% and 38.2%, respectively). The interaction between the antiretrovirals and SARS-CoV-2 RdRp, ExoN-NSP10 and 3CLpro yielded favorable binding energies (from −4.9 kcal/mol to −7.7 kcal/mol) using bioinformatics methods.
Lamivudine, emtricitabine and raltegravir showed in vitro antiviral effects against the D614G strain of SARS-CoV-2. Raltegravir was the compound with the greatest in vitro antiviral potential at low concentrations, and it showed the highest binding affinities with crucial SARS-CoV-2 proteins during the viral replication cycle. However, further studies on the therapeutic utility of raltegravir in patients with COVID-19 are required.
Citation: Maria I. Zapata-Cardona, Lizdany Florez-Alvarez, Ariadna L. Guerra-Sandoval, Mateo Chvatal-Medina, Carlos M. Guerra-Almonacid, Jaime Hincapie-Garcia, Juan C. Hernandez, Maria T. Rugeles, Wildeman Zapata-Builes. In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach[J]. AIMS Microbiology, 2023, 9(1): 20-40. doi: 10.3934/microbiol.2023002
[1] | Usman Babar, Haidar Ali, Shahid Hussain Arshad, Umber Sheikh . Multiplicative topological properties of graphs derived from honeycomb structure. AIMS Mathematics, 2020, 5(2): 1562-1587. doi: 10.3934/math.2020107 |
[2] | Ali Al Khabyah . Mathematical aspects and topological properties of two chemical networks. AIMS Mathematics, 2023, 8(2): 4666-4681. doi: 10.3934/math.2023230 |
[3] | R. Aguilar-Sánchez, J. A. Mendez-Bermudez, José M. Rodríguez, José M. Sigarreta . Multiplicative topological indices: Analytical properties and application to random networks. AIMS Mathematics, 2024, 9(2): 3646-3670. doi: 10.3934/math.2024179 |
[4] | Fei Yu, Hifza Iqbal, Saira Munir, Jia Bao Liu . M-polynomial and topological indices of some transformed networks. AIMS Mathematics, 2021, 6(12): 13887-13906. doi: 10.3934/math.2021804 |
[5] | Ali Al Khabyah, Haseeb Ahmad, Ali Ahmad, Ali N. A. Koam . A uniform interval-valued intuitionistic fuzzy environment: topological descriptors and their application in neural networks. AIMS Mathematics, 2024, 9(10): 28792-28812. doi: 10.3934/math.20241397 |
[6] | Sumiya Nasir, Nadeem ul Hassan Awan, Fozia Bashir Farooq, Saima Parveen . Topological indices of novel drugs used in blood cancer treatment and its QSPR modeling. AIMS Mathematics, 2022, 7(7): 11829-11850. doi: 10.3934/math.2022660 |
[7] | Fozia Bashir Farooq . Implementation of multi-criteria decision making for the ranking of drugs used to treat bone-cancer. AIMS Mathematics, 2024, 9(6): 15119-15131. doi: 10.3934/math.2024733 |
[8] | Jung-Chao Ban, Chih-Hung Chang . Entropy dimension of shifts of finite type on free groups. AIMS Mathematics, 2020, 5(5): 5121-5139. doi: 10.3934/math.2020329 |
[9] | Ali N. A. Koam, Ali Ahmad, Azeem Haider, Moin A. Ansari . Computation of eccentric topological indices of zero-divisor graphs based on their edges. AIMS Mathematics, 2022, 7(7): 11509-11518. doi: 10.3934/math.2022641 |
[10] | Yanjie Wang, Beibei Zhang, Bo Cao . On the number of zeros of Abelian integrals for a kind of quadratic reversible centers. AIMS Mathematics, 2023, 8(10): 23756-23770. doi: 10.3934/math.20231209 |
Drug repurposing is a valuable strategy for rapidly developing drugs for treating COVID-19. This study aimed to evaluate the antiviral effect of six antiretrovirals against SARS-CoV-2 in vitro and in silico.
The cytotoxicity of lamivudine, emtricitabine, tenofovir, abacavir, efavirenz and raltegravir on Vero E6 was evaluated by MTT assay. The antiviral activity of each of these compounds was evaluated via a pre-post treatment strategy. The reduction in the viral titer was assessed by plaque assay. In addition, the affinities of the antiretroviral interaction with viral targets RdRp (RNA-dependent RNA polymerase), ExoN-NSP10 (exoribonuclease and its cofactor, the non-structural protein 10) complex and 3CLpro (3-chymotrypsin-like cysteine protease) were evaluated by molecular docking.
Lamivudine exhibited antiviral activity against SARS-CoV-2 at 200 µM (58.3%) and 100 µM (66.7%), while emtricitabine showed anti-SARS-CoV-2 activity at 100 µM (59.6%), 50 µM (43.4%) and 25 µM (33.3%). Raltegravir inhibited SARS-CoV-2 at 25, 12.5 and 6.3 µM (43.3%, 39.9% and 38.2%, respectively). The interaction between the antiretrovirals and SARS-CoV-2 RdRp, ExoN-NSP10 and 3CLpro yielded favorable binding energies (from −4.9 kcal/mol to −7.7 kcal/mol) using bioinformatics methods.
Lamivudine, emtricitabine and raltegravir showed in vitro antiviral effects against the D614G strain of SARS-CoV-2. Raltegravir was the compound with the greatest in vitro antiviral potential at low concentrations, and it showed the highest binding affinities with crucial SARS-CoV-2 proteins during the viral replication cycle. However, further studies on the therapeutic utility of raltegravir in patients with COVID-19 are required.
Protein Data Bank identification code;
RNA-dependent RNA polymerase;
Exoribonuclease and its cofactor, the non-structural protein 10 complex;
3-chymotrypsin-like cysteine protease
Graph theory has provided the researcher with various useful tools, such as graph labeling, locating numbers and topological indices. Graph theory subject has many applications and implementations in different research subjects like chemistry, medicine and engineering. A graph can be recognized by a numeric value, a polynomial, a sequence of numbers or a matrix. The representation of the chemical compound in terms of diagram, known as its molecular graph, in which its atoms and the chemical bonding between them represent the nodes and edges, respectively. Recently, a new subject caught attention of the researchers was introduced, which is the combination of chemistry, information science and mathematics is called Cheminformatics, which studies QSAR/QSPR relationship, bioactivity and characterization of chemical compounds [1].
The topological index is a numeric value related with chemical compositions maintaining the correlation of chemical structures with many physico-chemical properties, chemical reactivity or biological activity. Topological indices are prepared on the grounds of the transformation of a chemical network into a number that describes the topology of the chemical network. Some of the main types of topological indices of graphs are distance-based topological indices, degree-based topological indices, and counting-related topological indices. Recently, numerous researchers have found topological indices for the study of fundamental properties of molecular graph or network. These networks have very motivating topological properties which have been considered in different characteristics in [2,3,4,5,6,7,8,9].
Let G=(V,E) be a simple connected graph, with V be the vertex set and E be the edge set of graph G, with order |V|=p, size |E|=q. The number of edges incident with a vertex ω is known as the degree of ω, denoted by ζ(ω). The reverse vertex degree (R(ω)) was introduced by Kulli [10] defined as: R(ω)=1−ζ(ω)+Δ, where Δ denoted the maximum degree of the given graph. Let ER(ω),R(μ) represents the edge partition of the given graph based on reverse degree of end vertices of an edge ωμ∈E and |ER(ω),R(μ)| represents its cardinality. There are detailed variations of topological indices mainly distance-based and degree-based indices, see [11,12,13,14,15,16]. Milan Randic [30] was the first who defined the degree-based indices and its reverse Randic index is defined as:
RRα(G)=∑ωμ∈E(G)(R(ω)×R(μ))α,α=12,−12,1,−1. | (1.1) |
Estrada et al. presented the atom bond connectivity (ABC) index in [18] and the reverse atom bond connectivity (RABC) is defined as:
RABC(G)=∑ωμ∈E(G)√R(ω)+R(μ)−2R(ω)×R(μ) | (1.2) |
Vukicevic and Furtula defined the geometric arithmetic (GA) index in [19] and the reverse geometric arithmetic (RGA) is presented as:
RGA(G)=∑ωμ∈E(G)2√R(ω)×R(μ)R(ω)+R(μ) | (1.3) |
Gutman et al. [20,21] defined the first and second Zagreb and its reverse indices as:
RM1(G)=∑ωμ∈E(G)(R(ω)+R(μ)) | (1.4) |
RM2(G)=∑ωμ∈E(G)(R(ω)×R(μ)) | (1.5) |
Shirdel et al. [22] introduced hyper Zagreb index. We defined the reverse hyper Zagreb index as:
RHM(G)=∑ωμ∈E(G)(R(ω)+R(μ))2 | (1.6) |
Furtula and Gutman [23] accomplished the forgotten index and its reverse forgotten index as:
RF(G)=∑ωμ∈E(G)((R(ω))2+(R(μ))2) | (1.7) |
Augmented Zagreb index was introduced by Furtula et al. [24] and the reverse augmented Zagreb index as:
RAZI(G)=∑ωμ∈E(G)(R(ω)×R(μ)R(ω)+R(μ)−2)3 | (1.8) |
Ranjini et al. [25] introduced the first redefined, second redefined and third redefined Zagreb indices. The reverse first redefined, second redefined and third redefined Zagreb indices are defined as:
RReZ1(G)=∑ωμ∈E(G)R(ω)+R(μ)R(ω)×R(μ) | (1.9) |
RReZ2(G)=∑ωμ∈E(G)R(ω)×R(μ)R(ω)+R(μ) | (1.10) |
RReZ3(G)=∑ωμ∈E(G)(R(ω)+R(μ))(R(ω)×R(μ)) | (1.11) |
For latest results on topological indices see [26,27,28,29,31,32,33,34,35]. In this paper, we compute the exact results for all the above reverse indices.
With the help of complete graphs of order 3 (K3), Chen et al. [36] assembled a hexagonal mesh. In terms of chemistry, these K3 graphs are also called oxide graphs. The Figure 1 is obtained by joining these K3 graphs. Two dimensional mesh graph HX(2) (see Figure 1 (a)), is obtained by joining six K3 graphs and three dimensional mesh graph HX(3) (see Figure 1 (b)) is obtained by putting K3 graphs around all side of HX(2). Furthermore, repeating the same process by putting the t K3 graph around each hexagon, we obtained the tth hexagonal mesh. To be noted that the one dimensional hexagonal mesh graph does not exist.
Simonraj et al. [37] created the new network which is named as third type of hex-derived networks. The graphically construction algorithm for third type of hexagonal hex-derived network HHDN3(t) (see Figure 2), triangular hex-derived network THDN3(t) (see Figure 3) and rectangular hex-derived network RHDN3(t) (see Figure 4) are defined in [38,39] and they determined some topological indices of these new derived networks. Some networks such as hexagonal, honeycomb, and grid networks, for instance, endure closeness to atomic or molecular lattice configurations. Related research that applies this theory and which could get additional advantages from the visions of the new research is found in [40,41,42,43,44,45,46].
Let Γ1=HHDN3(t) be the third type of hexagonal hex-derived network which is shown in Figure 2, where t≥4. The graph Γ1 has 21t2−39t+19 vertices from which 18t2−36t+18 vertices of reverse degree 15, 4 vertices of reverse degree 12, 6t−12 vertices of reverse degree 9 and 3t2−9t+9 vertices of reverse degree 1. There are 63t2−123t+60 number of edges of Γ1 is partitioned into nine classes based on their reverse degrees which are given in Eq (3.1).
|ER(ω),R(μ)(Γ1)|={9t2−33t+30,for; R(ω)=1,R(μ)=112t−24,for; R(ω)=9,R(μ)=16t−18,for; R(ω)=9,R(μ)=96,for; R(ω)=12,R(μ)=112,for; R(ω)=12,R(μ)=936t2−108t+84,for; R(ω)=15,R(μ)=136t−72,for; R(ω)=15,R(μ)=924,for; R(ω)=15,R(μ)=1218t2−36t+18,for; R(ω)=15,R(μ)=15 | (3.1) |
In the next theorem, we will calculate the reverse Randic index, reverse Zagreb indices, reverse forgotten index for Γ1 graph.
Theorem 3.1. Let Γ1 be the third type of hexagonal hex-derived network, then
● RRα(Γ1)=[9+36(15)α+18(225)α]t2+[−33+12(9)α+6(81)α−108(15)α+36(135)α−36(225)α]t+30−24(9)α−18(81)α+6(12)α+12(108)α+84(15)α−72(135)α+24(180)α+18(225)α
● RM1(Γ1)=1134t2−1782t+630
● RM2(Γ1)=4599t2−4299t−366
● RHM(Γ1)=25452t2−36300t+11922
● RF(Γ1)=16254t2−27702t+12654
Proof. Let Γ1 be the third type of hexagonal hex-derived network which is shown in Figure 2. The order of hexagonal hex derived network Γ1 is p=|Γ1|=21t2−39t+19 and size is q=63t2−123t+60. The edge partitioned of Γ1 based on their reverse degrees are shown in Eq (3.1). Reverse Randic index can be calculated by using Eq (3.1). Thus, from Eq (1.1), it follows,
RRα(Γ1)=(1)α|E1,1(Γ1)|+(9)α|E9,1(Γ1)|+(81)α|E9,9(Γ1)|+(12)α|E12,1(Γ1)|+(108)α|E12,9(Γ1)|+(15)α|E15,1(Γ1)|+(135)α|E15,9(Γ1)|+(180)α|E15,12(Γ1)|+(225)α|E15,15(Γ1)|.
=(9t2−33t+30)+(9)α(12t−24)+(81)α(6t−18)+(12)α(6)+(108)α(12)+(15)α(36t2−108t+84)+(135)α(36t−72)+(180)α(24)+(225)α(18t2−36t+18).
=[9+36(15)α+18(225)α]t2+[−33+12(9)α+6(81)α−108(15)α+36(135)α−36(225)α]t+30−24(9)α−18(81)α+6(12)α+12(108)α+84(15)α−72(135)α+24(180)α+18(225)α. Put α=1 and after some calculation, we get reverse second Zagreb index RM2(Γ1) as:
RM2(Γ1)=4599t2−4299t−366. | (3.2) |
Using the Eq (1.4), we can determine the reverse first Zagreb index RM1(Γ1) as:
RM1(Γ1)=2×|E1,1(Γ1)|+10×|E9,1(Γ1)|+18×|E9,9(Γ1)|+13×|E12,1(Γ1)|+21×|E12,9(Γ1)|+16×|E15,1(Γ1)|+24×|E15,9(Γ1)|+27×|E15,12(Γ1)|+30×|E15,15(Γ1)|.
By putting the values of from equation (3.1) and after simplification, we obtain:
RM1(Γ1)=1134t2−1782t+630. | (3.3) |
Using the Eq (1.6), we can determine the reverse hyper Zagreb index RHM(Γ1) as:
RHM(Γ1)=4×|E1,1(Γ1)|+100×|E9,1(Γ1)|+324×|E9,9(Γ1)|+169×|E12,1(Γ1)|+441×|E12,9(Γ1)|+256×|E15,1(Γ1)|+576×|E15,9(Γ1)|+729×|E15,12(Γ1)|+900×|E15,15(Γ1)|.
After simplification, we get
RHM(Γ1)=25452t2−36300t+11922 |
Using the Eq (1.7), we can determine the reverse forgotten index RF(Γ1)) as:
RF(Γ1))=2×|E1,1(Γ1)|+82×|E9,1(Γ1)|+162×|E9,9(Γ1)|+145×|E12,1(Γ1)|+225×|E12,9(Γ1)|+226×|E15,1(Γ1)|+306×|E15,9(Γ1)|+369×|E15,12(Γ1)|+450×|E15,15(Γ1)|.
After simplification, we get
RF(Γ1)=16254t2−27702t+12654 |
In the next theorem, we will calculate the reverse atom bond connectivity index, reverse geometric arithmetic index for Γ1 graph.
Theorem 3.2. Let Γ1 be the third type of hexagonal hex-derived network, then
● RABC(Γ1)=(12√2105+12√75)t2+(8√2+83−36√2105+4√3305−24√75)t−8−16√2+√33+2√573+28√2105−8√3305+4√5+12√75
● RGA(Γ1)=(27+9√152)t2+(−2795−9√152)t+785+792√391−15√152+32√53.
Proof. The reverse atom bond connectivity (RABC(Γ1)), can be determined by using Eq (1.2) and Eq (3.1), as follows:
RABC(Γ1)=0×|E1,1(Γ1)|+√89×|E9,1(Γ1)|+√1681×|E9,9(Γ1)|+√1112×|E12,1(Γ1)|+√19108×|E12,9(Γ1)|+√1415×|E15,1(Γ1)|+√22135×|E15,9(Γ1)|+√25180×|E15,12(Γ1)|+√28225×|E15,15(Γ1)|.
After some simplification, we get
RABC(Γ1)=(12√2105+12√75)t2+(8√2+83−36√2105+4√3305−24√75)t−8−16√2+√33+2√573+28√2105−8√3305+4√5+12√75.
The reverse geometric arithmetic (RGA(Γ1)), can be determined by using Eq (1.3) and Eq (3.1), as follows:
RGA(Γ1)=|E1,1(Γ1)|+2√910×|E9,1(Γ1)|+2√8118×|E9,9(Γ1)|+2√1213×|E12,1(Γ1)|+2√10821×|E12,9(Γ1)|+2√1516×|E15,1(Γ1)|+2√13524×|E15,9(Γ1)|+2√18027×|E15,12(Γ1)|+2√22530×|E15,15(Γ1)|.
After some simplification, we get
RGA(Γ1)=(27+9√152)t2+(−2795−9√152)t+785+792√391−15√152+32√53. In the next theorems, we will calculate the reverse redefined Zagreb indices for Γ1 graph.
Theorem 3.3. Let Γ1 be the third type of hexagonal hex-derived network, then
● RReZ1(Γ1)=294t25−2474t15+362930
● RReZ2(Γ1)=693t24−2949t20−939071820
● RReZ3(Γ1)=130158t2−142518t+24828
Proof. Reverse redefined Zagreb indices can be calculated by using Eq (3.1), the RReZ1(Γ1) by using Eq (1.9) as follows:
RReZ1(Γ1)=2×|E1,1(Γ1)|+109×|E9,1(Γ1)|+1881×|E9,9(Γ1)|+1312×|E12,1(Γ1)|+21108×|E12,9(Γ1)|+1615×|E15,1(Γ1)|+24135×|E15,9(Γ1)|+27108×|E15,12(Γ1)|+30225×|E15,15(Γ1)|.
After some simplification, we get
RReZ1(Γ1)=294t25−2474t15+362930. |
The RReZ2(Γ1) can be determined by using Eq (1.10) as follows:
RReZ2(Γ1)=12×|E1,1(Γ1)|+910×|E9,1(Γ1)|+8118×|E9,9(Γ1)|+1213×|E12,1(Γ1)|+10821×|E12,9(Γ1)|+1516×|E15,1(Γ1)|+13524×|E15,9(Γ1)|+10827×|E15,12(Γ1)|+22530×|E15,15(Γ1)|.
After some simplification, we get
RReZ2(Γ1)=693t24−2949t20−939071820. |
The RReZ3(Γ1) can be calculated by using Eq (1.11) as follows:
RReZ3(Γ1)=2×|E1,1(Γ1)|+90×|E9,1(Γ1)|+1458×|E9,9(Γ1)|+156×|E12,1(Γ1)|+2268×|E12,9(Γ1)|+240×|E15,1(Γ1)|+3240×|E15,9(Γ1)|+2916×|E15,12(Γ1)|+6750×|E15,15(Γ1)|.
After some simplification, we get
RReZ3(Γ1)=130158t2−142518t+24828. |
Let Γ2=THDN3(t) be the third type of triangular hex-derived network which is shown in Figure 3, where t≥4. The graph Γ2 has 7t2−11t+62 vertices. There are 21t2−39t+182 number of edges of Γ2 is partitioned into six classes based on their reverse degrees which are given in Eq (4.1). Now we calculated reverse degree based indices such as: reverse Randic index RRα, reverse atom bond connectivity index RABC, reverse geometric arithmetic index RGA, first reverse Zagreb index RM1, second reverse Zagreb index RM2, reverse forgotten index RF, reverse hyper Zagreb index RHM and reverse redefined Zagreb indices for Γ2 graph.
|ER(ω),R(μ)(Γ2)|={3t22−21t2+18,for; R(ω)=1,R(μ)=16t−18,for; R(ω)=9,R(μ)=13t−6,for; R(ω)=9,R(μ)=96t2−30t+36,for; R(ω)=15,R(μ)=118t−30,for; R(ω)=15,R(μ)=93t2−6t+9,for; R(ω)=15,R(μ)=15 | (4.1) |
In the next theorem, we will calculate the reverse Randic index, reverse Zagreb indices, reverse forgotten index for Γ2 graph.
Theorem 4.1. Let Γ2 be the third type of triangular hex-derived network, then
● RRα(Γ2)=(32+6(15)α+3(225)α)t2+(−212+6(9)α+3(81)α−30(15)α+18(135)α−6(225)α)t+18−18(9)α−6(81)α+36(15)α−30(135)α+9(225)α.
● RM1(Γ2)=189t2−135t−126
● RM2(Γ2)=1533t22+1833t2−2115
● RHM(Γ2)=4242t2−1182t−3636
● RF(Γ2)=2709t2−3015t+594
Proof. Let Γ2 be the third type of triangular hex-derived network which is shown in Figure 3. The order of triangular hex derived network Γ2 is p=|Γ2|=7t2−11t+62 and size is q=21t2−39t+182. The edge partitioned of Γ2 based on their reverse degrees are shown in Eq (4.1). Reverse Randic index can be calculated by using Eq (4.1). Thus, from Eq (1.1), it follows,
RRα(Γ2)=(1)α|E1,1(Γ2)|+(9)α|E9,1(Γ2)|+(81)α|E9,9(Γ2)|+(15)α|E15,1(Γ2)|+(135)α|E15,9(Γ2)|+(225)α|E15,15(Γ2)|.
After simplification, we get
RRα(Γ2)=(32+6(15)α+3(225)α)t2+(−212+6(9)α+3(81)α−30(15)α+18(135)α−6(225)α)t+18−18(9)α−6(81)α+36(15)α−30(135)α+9(225)α.
Put α=1 and after some calculation, we get reverse second Zagreb index RM2(Γ2) as:
RM2(Γ2)=1533t22+1833t2−2115 | (4.2) |
Using the Eq (1.4), we can determine the reverse first Zagreb index RM1(Γ2) as:
RM1(Γ2)=2×|E1,1(Γ1)|+10×|E9,1(Γ1)|+18×|E9,9(Γ1)|+16×|E15,1(Γ1)|+24×|E15,9(Γ1)|+30×|E15,15(Γ1)|.
By putting the values of from Eq (4.1) and after simplification, we obtain:
RM1(Γ2)=189t2−135t−126 | (4.3) |
Using the Eq (1.6), we can determine the reverse hyper Zagreb index RHM(Γ2) as:
RHM(Γ2)=4×|E1,1(Γ2)|+100×|E9,1(Γ2)|+324×|E9,9(Γ2)|+256×|E15,1(Γ2)|+576×|E15,9(Γ2)|+900×|E15,15(Γ2)|.
After simplification, we get
RHM(Γ2)=4242t2−1182t−3636. |
Using the Eq (1.7), we can determine the reverse forgotten index RF(Γ2)) as:
RF(Γ2))=2×|E1,1(Γ2)|+82×|E9,1(Γ2)|+162×|E9,9(Γ2)|+226×|E15,1(Γ2)|+306×|E15,9(Γ2)|+450×|E15,15(Γ2)|.
After simplification, we get
RF(Γ2)=2709t2−3015t+594. |
In the next theorem, we will calculate the reverse atom bond connectivity index, reverse geometric arithmetic index for Γ2 graph.
Theorem 4.2. Let Γ2 be the third type of triangular hex-derived network, then
● RABC(Γ2)=(2√2105+2√75)t2+(4√2+43−2√210+2√3305−4√75)t−83−12√2+12√2105−2√3303+6√75
● RGA(Γ2)=(92+3√154)t2+(−9910+3√154)t+515−3√15.
Proof. The reverse atom bond connectivity (RABC(Γ2)), can be determined by using Eq (1.2) and Eq (4.1), as follows:
RABC(Γ2)=0×|E1,1(Γ2)|+√89×|E9,1(Γ2)|+√1681×|E9,9(Γ2)|+√1415×|E15,1(Γ2)|+√22135×|E15,9(Γ2)|+√28225×|E15,15(Γ2)|.
After some simplification, we get
RABC(Γ2)=(2√2105+2√75)t2+(4√2+43−2√210+2√3305−4√75)t−83−12√2+12√2105−2√3303+6√75.
The reverse geometric arithmetic (RGA(Γ2)), can be determined by using Eq (1.3) and Eq (4.1), as follows:
RGA(Γ2)=|E1,1(Γ2)|+2√910×|E9,1(Γ2)|+2√8118×|E9,9(Γ2)|+2√1516×|E15,1(Γ2)|+2√13524×|E15,9(Γ2)|+2√22530×|E15,15(Γ2)|.
After some simplification, we get
RGA(Γ2)=(92+3√154)t2+(−9910+3√154)t+515−3√15. |
In the next theorems, we will calculate the reverse redefined Zagreb indices for Γ2 graph.
Theorem 4.3. Let Γ2 be the third type of triangular hex-derived network, then
● RReZ1(Γ2)=49t25−649t15+73415
● RReZ2(Γ2)=231t28+1671t40−101710
● RReZ3(Γ2)=21693t2+15513t−38142.
Proof. Reverse redefined Zagreb indices can be calculated by using Eq (4.1), the RReZ1(Γ2) by using Eq (1.9) as follows:
RReZ1(Γ2)=2×|E1,1(Γ2)|+109×|E9,1(Γ2)|+1881×|E9,9(Γ2)|+1615×|E15,1(Γ2)|+24135×|E15,9(Γ2)|+30225×|E15,15(Γ2)|.
After some simplification, we get
RReZ1(Γ2)=49t25−649t15+73415. |
The RReZ2(Γ2) can be determined by using Eq (1.10) as follows:
RReZ2(Γ2)=12×|E1,1(Γ2)|+910×|E9,1(Γ2)|+8118×|E9,9(Γ2)|+1516×|E15,1(Γ2)|+13524×|E15,9(Γ2)|+22530×|E15,15(Γ2)|.
After some simplification, we get
RReZ2(Γ2)=231t28+1671t40−101710. |
The RReZ3(Γ2) can be calculated by using Eq (1.11) as follows:
RReZ3(Γ2)=2×|E1,1(Γ2)|+90×|E9,1(Γ2)|+1458×|E9,9(Γ2)|+240×|E15,1(Γ2)|+3240×|E15,9(Γ2)|+6750×|E15,15(Γ2)|.
After some simplification, we get
RReZ3(Γ2)=21693t2+15513t−38142. |
In this section, we calculate certain reverse degree based topological indices of the third type of rectangular hex-derived network, RHDN3(t,w) of dimension t=w. Now we calculated reverse degree based indices such as: reverse Randic index RRα, reverse atom bond connectivity index RABC, reverse geometric arithmetic index RGA, first reverse Zagreb index RM1, second reverse Zagreb index RM2, reverse forgotten index RF, reverse augmented Zagreb index RAZI, reverse hyper Zagreb index RHM and reverse redefined Zagreb indices for Γ3 graph.
|ER(ω),R(μ)(Γ3)|={3t2−16t+21,for; R(ω)=1,R(μ)=18t−20,for; R(ω)=9,R(μ)=14t−10,for; R(ω)=9,R(μ)=92,for; R(ω)=12,R(μ)=14,for; R(ω)=12,R(μ)=912t2−48t+48,for; R(ω)=15,R(μ)=124t−44,for; R(ω)=15,R(μ)=98,for; R(ω)=15,R(μ)=126t2−12t+10,for; R(ω)=15,R(μ)=15 | (5.1) |
In the next theorem, we will calculate the reverse Randic index, reverse Zagreb indices, reverse forgotten index for Γ3 graph.
Theorem 5.1. Let Γ3 be the third type of rectangular hex-derived network, then
● RRα(Γ3)=(3+12(15)α+6(225)α)t2+(−16+8(9)α+4(81)α−48(15)α+24(135)α−12(225)α)t+21−20(9)α−10(81)α+2(12)α+4(108)α+48(15)α−44(135)α+8(180)α+10(225)α
● RM1(Γ3)=378t2−432t
● RM2(Γ3)=1533t2+200t−2043
● RHM(Γ3)=8484t2−7232t−1278
● RF(Γ3)=5418t2−7632t+2808.
Proof. Let Γ3 be the third type of rectangular hex-derived network which is shown in Figure 4. The order of hexagonal hex derived network Γ3 is p=|Γ1|=7t2−12t+6 and size is q=21t2−40t+19. The edge partitioned of Γ3 based on their reverse degrees are shown in Eq (5.1). Reverse Randic index can be calculated by using Eq (5.1). Thus, from Eq (1.1), it follows,
RRα(Γ3)=(1)α|E1,1(Γ3)|+(9)α|E9,1(Γ3)|+(81)α|E9,9(Γ3)|+(12)α|E12,1(Γ3)|+(108)α|E12,9(Γ3)|+(15)α|E15,1(Γ3)|+(135)α|E15,9(Γ3)|+(180)α|E15,12(Γ3)|+(225)α|E15,15(Γ3)|.
After Simplification, we get
RRα(Γ3)=(3+12(15)α+6(225)α)t2+(−16+8(9)α+4(81)α−48(15)α+24(135)α−12(225)α)t+21−20(9)α−10(81)α+2(12)α+4(108)α+48(15)α−44(135)α+8(180)α+10(225)α.
Put α=1 and after some calculation, we get reverse second Zagreb index RM2(Γ3) as:
RM2(Γ3)=1533t2+200t−2043. | (5.2) |
Using the Eq (1.4), we can determine the reverse first Zagreb index RM1(Γ3) as:
RM1(Γ3)=2×|E1,1(Γ3)|+10×|E9,1(Γ3)|+18×|E9,9(Γ3)|+13×|E12,1(Γ3)|+21×|E12,9(Γ3)|+16×|E15,1(Γ3)|+24×|E15,9(Γ3)|+27×|E15,12(Γ3)|+30×|E15,15(Γ3)|.
By putting the values of from Eq (5.1) and after simplification, we obtain:
RM1(Γ3)=378t2−432t. | (5.3) |
Using the Eq (1.6), we can determine the reverse hyper Zagreb index RHM(Γ3) as:
RHM(Γ3)=4×|E1,1(Γ3)|+100×|E9,1(Γ3)|+324×|E9,9(Γ3)|+169×|E12,1(Γ3)|+441×|E12,9(Γ3)|+256×|E15,1(Γ3)|+576×|E15,9(Γ3)|+729×|E15,12(Γ3)|+900×|E15,15(Γ3)|.
After simplification, we get
RHM(Γ3)=8484t2−7232t−1278. |
Using the Eq (1.7), we can determine the reverse forgotten index RF(Γ3)) as:
RF(Γ3))=2×|E1,1(Γ3)|+82×|E9,1(Γ3)|+162×|E9,9(Γ3)|+145×|E12,1(Γ3)|+225×|E12,9(Γ3)|+226×|E15,1(Γ3)|+306×|E15,9(Γ3)|+369×|E15,12(Γ3)|+450×|E15,15(Γ3)|.
After simplification, we get
RF(Γ3)=5418t2−7632t+2808. |
In the next theorem, we will calculate the reverse atom bond connectivity index, reverse geometric arithmetic index for Γ3 graph.
Theorem 5.2. Let Γ3 be the third type of rectangular hex-derived network, then
● RABC(Γ3)=(4√2105+4√75)t2+(16√23+169−16√2105+8√33015−8√75)t−409−40√23+√333+2√579+16√2105−44√33045+4√53+4√73.
● RGA(Γ3)=(9+3√152)t2−96t5+9+264√391−5√15+32√59.
Proof. The reverse atom bond connectivity (RABC(Γ3)), can be determined by using Eq (1.2) and Eq (5.1), as follows:
RABC(Γ3)=0×|E1,1(Γ3)|+√89×|E9,1(Γ3)|+√1681×|E9,9(Γ3)|+√1112×|E12,1(Γ3)|+√19108×|E12,9(Γ3)|+√1415×|E15,1(Γ3)|+√22135×|E15,9(Γ3)|+√25180×|E15,12(Γ3)|+√28225×|E15,15(Γ3)|.
After some simplification, we get
RABC(Γ3)=(4√2105+4√75)t2+(16√23+169−16√2105+8√33015−8√75)t−409−40√23+√333+2√579+16√2105−44√33045+4√53+4√73.
The reverse geometric arithmetic (RGA(Γ3)), can be determined by using Eq (1.3) and Eq (5.1), as follows:
RGA(Γ3)=|E1,1(Γ3)|+2√910×|E9,1(Γ3)|+2√8118×|E9,9(Γ3)|+2√1213×|E12,1(Γ3)|+2√10821×|E12,9(Γ3)|+2√1516×|E15,1(Γ3)|+2√13524×|E15,9(Γ3)|+2√18027×|E15,12(Γ3)|+2√22530×|E15,15(Γ3)|.
After some simplification, we get
RGA(Γ3)=(9+3√152)t2−96t5+9+264√391−5√15+32√59.
In the next theorems, we will calculate the reverse redefined Zagreb indices for Γ3 graph.
Theorem 5.3. Let Γ3 be the third type of rectangular hex-derived network, then
● RReZ1(Γ3)=98t25−3184t45+597790
● RReZ2(Γ3)=231t24+86t5−28460273
● RReZ3(Γ3)=43386t2−8240t−31614.
Proof. Reverse redefined Zagreb indices can be calculated by using Eq (5.1), the RReZ1(Γ3) by using Eq (1.9) as follows:
RReZ1(Γ3)=2×|E1,1(Γ3)|+109×|E9,1(Γ3)|+1881×|E9,9(Γ3)|+1312×|E12,1(Γ3)|+21108×|E12,9(Γ3)|+1615×|E15,1(Γ3)|+24135×|E15,9(Γ3)|+27108×|E15,12(Γ3)|+30225×|E15,15(Γ3)|.
After some simplification, we get
RReZ1(Γ3)=98t25−3184t45+597790. |
The RReZ2(Γ1) can be determined by using equation (1.10) as follows:
RReZ2(Γ3)=12×|E1,1(Γ3)|+910×|E9,1(Γ3)|+8118×|E9,9(Γ3)|+1213×|E12,1(Γ3)|+10821×|E12,9(Γ3)|+1516×|E15,1(Γ3)|+13524×|E15,9(Γ3)|+10827×|E15,12(Γ3)|+22530×|E15,15(Γ3)|.
After some simplification, we get
RReZ2(Γ3)=231t24+86t5−28460273. |
The RReZ3(Γ3) can be calculated by using Eq (1.11) as follows:
RReZ3(Γ3)=2×|E1,1(Γ3)|+90×|E9,1(Γ3)|+1458×|E9,9(Γ3)|+156×|E12,1(Γ3)|+2268×|E12,9(Γ3)|+240×|E15,1(Γ3)|+3240×|E15,9(Γ3)|+2916×|E15,12(Γ3)|+6750×|E15,15(Γ3)|.
After some simplification, we get
RReZ3(Γ3)=43386t2−8240t−31614. |
In this article, we have calculated the exact solutions of reverse degree-based topological descriptors for hex-derived networks of third type. Hex-derived network has a variety of useful applications in pharmacy, electronics, and networking. We obtained the reverse degree-based indices such as reverse Randic index, reverse atom bond connectivity index, reverse geometric arithmetic index, reverse Zagreb indices, reverse redefined Zagreb indices for hex derived networks. These results may be helpful for people working in computer science and chemistry who encounter hex-derived networks.
The authors declare that there is no conflict of financial interests regarding the publication of this paper.
[1] | W.H.O.WHO Director-General' opening remarks at the media briefing on COVID-19-11 March 2020, 2020. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. |
[2] |
Lopera TJ, Chvatal-Medina M, Florez-Alvarez L, et al. (2022) Humoral response to BNT162b2 vaccine against SARS-CoV-2 variants decays after six months. Front Immunol 13: 879036. https://doi.org/10.3389/fimmu.2022.879036 ![]() |
[3] |
Tada T, Zhou H, Dcosta BM, et al. (2021) Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera. iScience 24: 103341. https://doi.org/10.1016/j.isci.2021.103341 ![]() |
[4] |
Hoffmann M, Kruger N, Schulz S, et al. (2022) The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell 185: 447-456. https://doi.org/10.1016/j.cell.2021.12.032 ![]() |
[5] |
Wang MY, Zhao R, Gao LJ, et al. (2020) SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front Cell Infect Microbiol 10: 587269. https://doi.org/10.3389/fcimb.2020.587269 ![]() |
[6] |
Yadav R, Chaudhary JK, Jain N, et al. (2021) Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells 10: 821. https://doi.org/10.3390/cells10040821 ![]() |
[7] |
Yang H, Rao Z (2021) Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat Rev Microbiol 19: 685-700. https://doi.org/10.1038/s41579-021-00630-8 ![]() |
[8] |
Gao Y, Yan L, Huang Y, et al. (2020) Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science 368: 779-782. https://doi.org/10.1126/science.abb7498 ![]() |
[9] |
Lin S, Chen H, Chen Z, et al. (2021) Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity. Nucleic Acids Res 49: 5382-5392. https://doi.org/10.1093/nar/gkab320 ![]() |
[10] |
Baddock H, Brolih S, Yosaatmadja Y, et al. (2022) Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification. Nucleic Acids Res 50: 1484-1500. https://doi.org/10.1093/nar/gkab1303 ![]() |
[11] |
V'kovski P, Kratzel A, Steiner S, et al. (2021) Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol 19: 155-170. https://doi.org/10.1038/s41579-020-00468-6 ![]() |
[12] |
Mosquera-Yuqui F, Lopez-Guerra N, Moncayo-Palacio EA (2020) Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations. J Biomol Struct Dyn 40: 2010-2023. https://doi.org/10.1080/07391102.2020.1835716 ![]() |
[13] |
Peele KA, Potla Durthi C, Srihansa T, et al. (2020) Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study. Inform Med Unlocked 19: 100345. https://doi.org/10.1016/j.imu.2020.100345 ![]() |
[14] |
Cao B, Wang Y, Wen D, et al. (2020) A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382: 1787-1799. https://doi.org/10.1056/NEJMoa2001282 ![]() |
[15] |
Arabi YM, Gordon AC, Derde LPG, et al. (2021) Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med 47: 867-886. https://doi.org/10.1007/s00134-021-06448-5 ![]() |
[16] |
Beck BR, Shin B, Choi Y, et al. (2020) Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Comput Struct Biotechnol J 18: 784-790. https://doi.org/10.1016/j.csbj.2020.03.025 ![]() |
[17] |
Jordaan MA, Ebenezer O, Damoyi N, et al. (2020) Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz. Heliyon 6: e04642. https://doi.org/10.1016/j.heliyon.2020.e04642 ![]() |
[18] |
Indu P, Rameshkumar MR, Arunagirinathan N, et al. (2020) Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach. J Infect Public Health 13: 1856-1861. https://doi.org/10.1016/j.jiph.2020.10.015 ![]() |
[19] | Jockusch S, Tao C, Li X, et al. (2020) Triphosphates of the Two Components in DESCOVY and TRUVADA are Inhibitors of the SARS-CoV-2 Polymerase. bioRxiv : 2020. https://doi.org/10.1101/2020.04.03.022939 |
[20] |
Alavian G, Kolahdouzan K, Mortezazadeh M, et al. (2021) Antiretrovirals for Prophylaxis Against COVID-19: A Comprehensive Literature Review. J Clin Pharmacol 61: 581-590. https://doi.org/10.1002/jcph.1788 ![]() |
[21] | Arts EJ, Hazuda DJ (2012) HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med 2: a007161. https://doi.org/10.1101/cshperspect.a007161 |
[22] |
Kumar Y, Singh H, Patel CN (2020) In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. J Infect Public Health 13: 1210-1223. https://doi.org/10.1016/j.jiph.2020.06.016 ![]() |
[23] |
Jo S, Kim S, Yoo J, et al. (2021) A study of 3CLpros as promising targets against SARS-CoV and SARS-CoV-2. Microorganisms 9: 756. https://doi.org/10.3390/microorganisms9040756 ![]() |
[24] |
Garcia-Trejo JJ, Ortega R, Zarco-Zavala M (2021) Putative repurposing of lamivudine, a nucleoside/nucleotide analogue and antiretroviral to improve the outcome of cancer and COVID-19 patients. Front Oncol 11: 664794. https://doi.org/10.3389/fonc.2021.664794 ![]() |
[25] | Clososki CG, Soldi RA, Moreira Silva R, et al. (2020) Tenofovir disoproxil fumarate: new chemical developments and encouraging in vitro biological results for SARS-CoV-2. J Braz Chem Soc 31: 1552-1556. https://doi.org/10.21577/0103-5053.20200106 |
[26] |
Copertino D, Lima B, Duarte R, et al. (2020) Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection. J Biomol Struct Dyn 40: 7367-7380. https://doi.org/10.26434/chemrxiv.12250199 ![]() |
[27] |
Chien M, Anderson TK, Jockusch S, et al. (2020) Nucleotide analogues as inhibitors of SARS-CoV-2 polymerase, a key drug target for COVID-19. J Proteome Res 19: 4690-4697. https://doi.org/10.1021/acs.jproteome.0c00392 ![]() |
[28] |
Xie X, Muruato AE, Zhang X, et al. (2020) A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat Commun 11: 5214. https://doi.org/10.1038/s41467-020-19055-7 ![]() |
[29] |
Martinec O, Huliciak M, Staud F, et al. (2019) Anti-HIV and anti-Hepatitis C virus drugs inhibit P-Glycoprotein efflux activity in Caco-2 Cells and precision-cut rat and human intestinal slices. Antimicrob Agents Chemother 63: e00910-00919. https://doi.org/10.1128/aac.00910-19 ![]() |
[30] |
Cong Y, Dyall J, Hart BJ, et al. (2016) Evaluation of the activity of lamivudine and zidovudine against Ebola virus. PLoS One 11: e0166318. https://doi.org/10.1371/journal.pone.0166318 ![]() |
[31] |
Zang R, Case JB, Yutuc E, et al. (2020) Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion. Proc Natl Acad Sci U S A 117: 32105-32113. https://doi.org/10.1073/pnas.2012197117 ![]() |
[32] |
Diaz FJ, Aguilar-Jimenez W, Florez-Alvarez L, et al. (2020) Isolation and characterization of an early SARS-CoV-2 isolate from the 2020 epidemic in Medellin, Colombia. Biomedica 40: 148-158. https://doi.org/10.7705/biomedica.5834 ![]() |
[33] | Chosewood L, Wilson D (2009) Biosafety in Microbiological and Biomedical Laboratories.US Department of Health and Human Services 415. |
[34] |
Zapata-Cardona MI, Florez-Alvarez L, Zapata-Builes W, et al. (2022) Atorvastatin effectively inhibits ancestral and two emerging variants of SARS-CoV-2 in vitro. Front Microbiol 13: 721103. https://doi.org/10.3389/fmicb.2022.721103 ![]() |
[35] |
Marin-Palma D, Tabares-Guevara JH, Zapata-Cardona MI, et al. (2021) Curcumin inhibits in vitro SARS-CoV-2 infection in vero E6 cells through multiple antiviral mechanisms. Molecules 26: 6900. https://doi.org/10.3390/molecules26226900 ![]() |
[36] | Zapata Cardona M, Florez-Alvarez L, Gomez-Gallego D, et al. (2022) Comparison among plaque assay, tissue culture infectious dose (TCID50) and real-time RT-PCR for SARS-CoV-2 variants quantification. Iran J Microbiol 14: 291-299. https://doi.org/10.18502/ijm.v14i3.9758 |
[37] | Moeller NH, Shi K, Demir O, et al. (2021) Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN. bioRxiv . https://doi.org/10.1101/2021.04.02.438274 |
[38] |
Su HX, Yao S, Zhao WF, et al. (2020) Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol Sin 41: 1167-1177. https://doi.org/10.1038/s41401-020-0483-6 ![]() |
[39] |
Berman HM, Westbrook J, Feng Z, et al. (2020) The protein data bank. Nucleic Acids Res 28: 235-242. https://doi.org/10.1093/nar/28.1.235 ![]() |
[40] |
Curry S (2015) Structural biology: a century-long journey into an unseen world. Interdiscip Sci Rev 40: 308-328. https://doi.org/10.1179/0308018815Z.000000000120 ![]() |
[41] | BIOVIA DSDiscovery studio visualizer software, version 16.1 2017. Available from: https://discover.3ds.com/discovery-studio-visualizer-download. |
[42] |
Chu CK, Gadthula S, Chen X, et al. (2006) Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-CoV). Antivir Chem Chemother 17: 285-289. https://doi.org/10.1177/095632020601700506 ![]() |
[43] |
Hanwell MD, Curtis DE, Lonie DC, et al. (2012) Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminformatics 4: 17. https://doi.org/10.1186/1758-2946-4-17 ![]() |
[44] |
Kokic G, Hillen HS, Tegunov D, et al. (2021) Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nat Commun 12: 279. https://doi.org/10.1038/s41467-020-20542-0 ![]() |
[45] |
Koulgi S, Jani V, Uppuladinne M, et al. (2020) Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2. RSC Advances 10: 26792-26803. https://doi.org/10.1039/D0RA04743K ![]() |
[46] |
Wang X, Sacramento CQ, Jockusch S, et al. (2022) Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture. Commun Biol 5: 154. https://doi.org/10.1038/s42003-022-03101-9 ![]() |
[47] | Nimgampalle M, Devanathan V, Saxena A (2020) Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets. J Biomol Struct Dyn : 1-13. https://doi.org/10.1080/07391102.2020.1782265 |
[48] |
Li Z, Li X, Huang YY, et al. (2020) Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs. Proc Natl Acad Sci USA 117: 27381. https://doi.org/10.1073/pnas.2010470117 ![]() |
[49] |
Jendele L, Krivak R, Skoda P, et al. (2019) PrankWeb: a web server for ligand binding site prediction and visualization. Nucleic Acids Res 47: W345-W349. https://doi.org/10.1093/nar/gkz424 ![]() |
[50] |
Schoning-Stierand K, Diedrich K, Fahrrolfes R, et al. (2020) ProteinsPlus: interactive analysis of protein–ligand binding interfaces. Nucleic Acids Res 48: W48-W53. https://doi.org/10.1093/nar/gkaa235 ![]() |
[51] |
Elfiky AA (2020) Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci 253: 117592. https://doi.org/10.1016/j.lfs.2020.117592 ![]() |
[52] |
Narayanan N, Nair DT (2021) Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs. Int J Biol Macromol 168: 272-278. https://doi.org/10.1016/j.ijbiomac.2020.12.038 ![]() |
[53] | Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31: 455-461. https://doi.org/10.1002/jcc.21334 |
[54] |
Ma Y, Wu L, Shaw N, et al. (2015) Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex. Proc Natl Acad Sci USA 112: 9436-9441. https://doi.org/10.1073/pnas.1508686112 ![]() |
[55] |
Frediansyah A, Tiwari R, Sharun K, et al. (2021) Antivirals for COVID-19: a critical review. Clin Epidemiol Glob Health 9: 90-98. https://doi.org/10.1016/j.cegh.2020.07.006 ![]() |
[56] |
Iacob S, Iacob DG (2020) SARS-CoV-2 Treatment approaches: numerous ptions, no certainty for a versatile virus. Front Pharmacol 11. https://doi.org/10.3389/fphar.2020.01224 ![]() |
[57] |
Papatheodoridis GV, Dimou E, Papadimitropoulos V (2002) Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance. Am J Gastroenterol 97: 1618-1628. https://doi.org/10.1111/j.1572-0241.2002.05819.x ![]() |
[58] | Joly V, Yeni P (1995) Treatment of HIV infection with nucleoside analogs: present status. Presse Med 24: 103-110. |
[59] |
Furman PA, Lam AM, Murakami E (2009) Nucleoside analog inhibitors of hepatitis C viral replication: recent advances, challenges and trends. Future Med Chem 1: 1429-1452. https://doi.org/10.4155/fmc.09.88 ![]() |
[60] |
Fiala M, Chow AW, Miyasaki K, et al. (1974) Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect at acid pH. J Infect Dis 129: 82-85. https://doi.org/10.1093/infdis/129.1.82 ![]() |
[61] |
Lisi L, Lacal PM, Barbaccia ML, et al. (2020) Approaching coronavirus disease 2019: mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2. Biochem Pharmacol 180: 11416. https://doi.org/10.1016/j.bcp.2020.114169 ![]() |
[62] | Smith EC, Blanc H, Surdel MC, et al. (2013) Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS pathogens 9: e100356. https://doi.org/10.1371/journal.ppat.1003565 |
[63] |
Agostini ML, Andres EL, Sims AC, et al. (2018) Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio 9: e00221-00218. https://doi.org/10.1128/mBio.00221-18 ![]() |
[64] |
Tran L, Tam DNH, Elhadad H, et al. (2022) Evaluation of COVID-19 protease and HIV inhibitors interactions. Acta Pharm 72: 1-8. https://doi.org/10.2478/acph-2022-0010 ![]() |
[65] |
Ullrich S, Nitsche C (2020) The SARS-CoV-2 main protease as drug target. Bioorganic Med Chem Lett 30: 127377. https://doi.org/10.1016/j.bmcl.2020.127377 ![]() |
[66] |
Pinzi L, Rastelli G (2019) Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci 20: 4331. https://doi.org/10.3390/ijms20184331 ![]() |
[67] |
Coupez B, Lewis RA (2006) Docking and scoring--theoretically easy, practically impossible?. Curr Med Chem 13: 2995-3003. https://doi.org/10.2174/092986706778521797 ![]() |
[68] |
Guedes IA, Pereira FSS, Dardenne LE (2018) Empirical scoring functions for structure-based virtual screening: applications, critical aspects, and challenges. Front Pharmacol 9: 1089. https://doi.org/10.3389/fphar.2018.01089 ![]() |
[69] |
Pruijssers AJ, George AS, Schafer A, et al. (2020) Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. Cell Rep 32: 107940. https://doi.org/10.1016/j.celrep.2020.107940 ![]() |
[70] |
Pruijssers AJ, Denison MR (2019) Nucleoside analogues for the treatment of coronavirus infections. Curr Opin Virol 35: 57-62. https://doi.org/10.1016/j.coviro.2019.04.002 ![]() |
[71] |
Koczor CA, Torres RA, Lewis W (2012) The role of transporters in the toxicity of nucleoside and nucleotide analogs. Expert Opin Drug Metab Toxicol 8: 665-676. https://doi.org/10.1517/17425255.2012.680885 ![]() |
[72] |
Eyer L, Nencka R, de Clercq E, et al. (2018) Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses. Antivir Chem Chemother 26: 2040206618761299. https://doi.org/10.1177/2040206618761299 ![]() |
[73] |
He X, Quan S, Xu M, et al. (2021) Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing. Proc Natl Acad Sci USA 118: e2025866118. https://doi.org/10.1073/pnas.2025866118 ![]() |
[74] |
Sankatsing SU, Beijnen JH, Schinkel AH, et al. (2004) P glycoprotein in human immunodeficiency virus type 1 infection and therapy. Antimicrob Agents Chemother 48: 1073-1081. https://doi.org/10.1128/aac.48.4.1073-1081.2004 ![]() |
[75] | ClinicalTrials.govClinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19 (ARTAN-C19) (2021). Available from: https://clinicaltrials.gov/ct2/show/NCT04712357?term=emtricitabine&cond=covid 19&draw=2&rank=1. |
[76] | ClinicalTrials.govClinical trial to evaluate the efficacy of different treatments in patients with COVID-19 (2021). Available from: https://clinicaltrials.gov/ct2/show/NCT04890626?term=emtricitabine&cond=covid-19&draw=2. |
[77] | ClinicalTrials.govDaily regimen of tenofovir/emtricitabine as prevention for COVID-19 in health care personnel in Colombia (2020). Available from: https://clinicaltrials.gov/ct2/show/NCT04519125?term=emtricitabine&cond=covid-19&draw=2&rank=3. |
[78] |
Parienti JJ, Prazuck T, Peyro-Saint-Paul L, et al. (2021) Effect of tenofovir disoproxil fumarate and emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial. EClinicalMedicine 38: 100993. https://doi.org/10.1016/j.eclinm.2021.100993 ![]() |
[79] |
Gaitan-Duarte HG, Alvarez-Moreno C, Rincon-Rodriguez CJ, et al. (2022) Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial. EClinicalMedicine 43: 101242. https://doi.org/10.1016/j.eclinm.2021.101242 ![]() |
[80] |
Del Amo J, Polo R, Moreno S, et al. (2020) Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study. Ann Intern Med 173: 536-541. https://doi.org/10.7326/M20-3689 ![]() |
[81] |
Moss DM, Kwan WS, Liptrott NJ, et al. (2011) Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir. Antimicrob Agents Chemother 55: 879-887. https://doi.org/10.1128/AAC.00623-10 ![]() |
[82] |
Khan RJ, Jha RK, Amera GM, et al. (2021) Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase. J Biomol Struct Dyn 39: 2679-2692. https://doi.org/10.1080/07391102.2020.1753577 ![]() |
[83] |
Molavi Z, Razi S, Mirmotalebisohi SA, et al. (2021) Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach. Biomed Pharmacother 138: 111544. https://doi.org/10.1016/j.biopha.2021.111544 ![]() |
[84] |
Tazikeh-Lemeski E, Moradi S, Raoufi R, et al. (2021) Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study. J Biomol Struct Dyn 39: 4633-4646. https://doi.org/10.1080/07391102.2020.1779133 ![]() |
![]() |
![]() |
1. | Saima Parveen, Fozia Bashir Farooq, Nadeem Ul Hassan Awan, Rakotondrajao Fanja, Muhammad Farooq Choudhary, Muhammad Kamran Jamil, Topological Indices of Drugs Used in Rheumatoid Arthritis Treatment and Its QSPR Modeling, 2022, 2022, 2314-4785, 1, 10.1155/2022/1562125 | |
2. | Ali N.A. Koam, Moin A. Ansari, Azeem Haider, Ali Ahmad, Muhammad Azeem, Topological properties of reverse-degree-based indices for sodalite materials network, 2022, 15, 18785352, 104160, 10.1016/j.arabjc.2022.104160 | |
3. | Ali N. A. Koam, Ali Ahmad, Ashfaq Ahmed Qummer, Gohar Ali, On the Study of Reverse Degree-Based Topological Properties for the Third Type of p th Chain Hex-Derived Network, 2021, 2021, 2314-4785, 1, 10.1155/2021/4540276 | |
4. | Usman Babar, Asim Naseem, Hani Shaker, Mian Muhammad Zobair, Haidar Ali, Andrea Penoni, Eccentricity-Based Topological Descriptors of First Type of Hex-Derived Network, 2022, 2022, 2090-9071, 1, 10.1155/2022/3340057 | |
5. | Vignesh Ravi, QSPR analysis of drugs used for treatment of hepatitis via reduced reverse degree-based topological descriptors, 2024, 99, 0031-8949, 105236, 10.1088/1402-4896/ad729d | |
6. | Muhammad Mudassar Hassan, Topological Descriptors of Molecular Networks via Reverse Degree, 2023, 1040-6638, 1, 10.1080/10406638.2023.2274473 | |
7. | Qasem M. Tawhari, Muhammad Naeem, Abdul Rauf, Muhammad Kamran Siddiqui, Oladele Oyelakin, Modeling and estimation of physiochemical properties of cancer drugs using entropy measures, 2025, 15, 2045-2322, 10.1038/s41598-025-87755-5 |